Antihypertensive drugs and risk of malignant diseases [2]

Lancet

Volumn 348, Issue 9026, 1996, Pages 542-

  Hardell, L ^a   Axelson, O ^a   Fredrikson, M ^a  

^a ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; HYDRALAZINE; METHYLDOPA; NIFEDIPINE; VERAPAMIL;

APOPTOSIS; CANCER; COLON CANCER; DIET; HEALTH HAZARD; HUMAN; HYPERTENSION; LETTER; PRIORITY JOURNAL; RISK;

EID: 0029759143     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)64695-8     Document Type: Letter

References (5)

1. R Horton Do calcium antagonists cause cancer? Lancet 348 1996 49
2. M Pahor JM Guralnik ME Salive MC Corti P Carbonin RJ Havlik Do calcium channel blockers increase the risk of cancer? Am J Hypertens 9 1996 695 699
3. L Hardell M Fredrikson O Axelson Case-control study on colon cancer regarding previous diseases and drug intake Int J Oncol 8 1996 439 444
4. DW Kaufman JP Kelly L Rosenberg PD Stolley ME Warshauer S Shapiro Hydrazine use in relation to cancers of the lung, colon, and rectum Eur J Clin Pharmacol 36 1989 259 264
5. Fakta 96. Pharmaceutical Market and Health Care 1996 The Swedish Association of the Pharmaceutical Industry Stockholm, Sweden